Go to Main Content

Purdue Self-Service

 

HELP | EXIT

Syllabus Information

 

Fall 2014
Jan 28, 2023
Transparent Image
Information Use this page to maintain syllabus information, learning objectives, required materials, and technical requirements for the course.

Syllabus Information
PHRM 84500 - Integrated Pharmacotherapy III
Associated Term: Fall 2014
Learning Outcomes: 1. Explain structure-function relationships of drugs used for the management of ischemic heart disease, heart failure, arrhythmias, Parkinson’s disease, dementia/Alzheimer’s disease, seizure disorders, MS, migraine, headache, psychotic disorders, bipolar disorder, depression, anxiety/sleep disorders, ADHD, pediatric psychiatric disorders, eating disorder, pain management, neuropathic pain, narcolepsy, and substance dependence. 2. Explain the pharmacology of drugs used for the management of ischemic heart disease, heart failure, arrhythmias, Parkinson’s disease, dementia/Alzheimer’s disease, seizure disorders, MS, migraine, headache, psychotic disorders, bipolar disorder, depression, anxiety/sleep disorders, ADHD, pediatric psychiatric disorders, eating disorder, pain management, neuropathic pain, narcolepsy, and substance dependence. 3. Describe the pathophysiologic processes responsible for specific disease states and integrate this knowledge into the therapeutic decision making process. 4. Evaluate various therapeutic alternatives for a given disease state in light of specific patient factors and design a patient-specific pharmacotherapeutic regimen. This will include assessing the effectiveness of therapy on the basis of clinical and laboratory parameters. 5. Describe adverse effects associated with drugs used for the management of ischemic heart disease, heart failure, arrhythmias, Parkinson’s disease, dementia/Alzheimer’s disease, seizure disorders, MS, migraine/headache, psychotic disorders, bipolar disorder, depression, anxiety/sleep disorders, ADHD, pediatric psychiatric disorders, eating disorder, pain management, neuropathic pain, narcolepsy, and substance dependence. 6. Design evidence-based drug therapy treatment plans for patients with ischemic heart disease, heart failure, arrhythmias, Parkinson’s disease, dementia/Alzheimer’s disease, seizure disorders, MS, migraine/headache, psychotic disorders, bipolar disorder, depression, anxiety/sleep disorders, ADHD, pediatric psychiatric disorders, eating disorder, pain management, neuropathic pain, narcolepsy, and substance dependence.
Required Materials:
Technical Requirements:


Return to Previous New Search
Transparent Image
Skip to top of page
Release: 8.7.2.4